1.
Alectinib and lorlatinib function by modulating EMT-related proteins and MMPs in NSCLC metastasis. Biomol Biomed [Internet]. 2021 Jun. 1 [cited 2025 Jul. 26];21(3):331-8. Available from: https://www.bjbms.org/ojs/index.php/bjbms/article/view/5066